Amphetamine Drug Testing Kits Instructions - Test Strips

INTRODUCTION

Amphetamine is a sympathomimetic amine whose biological effects include potent central nervous system stimulation, appetite reduction, hyperthermia, insomnia, increase in heart rate, increase in blood pressure, and the feeling of euphoria. It is usually taken orally, intravenously, or by smoking. Amphetamines are readily absorbed from the gastrointestinal tract. They are then either deactivated by the liver or excreted in its unchanged form in the urine. Amphetamine is metabolized into deaminated hippuric and benzoic acids and hydroxylated metabolites. Studies have shown that heavy dosage may result in permanent damage to certain essential nerve structures in the brain.

One Step Amphetamine Test is a fast, qualitative, and visually read, immunoassay for screening without the use of an instrument. The method employs a unique monoclonal antibody to electively identify amphetamine and its metabolites in test urine at or above the concentration of 1000 ng/mL. This product is not intended to monitor drug levels, but only to screen urine for the presence of amphetamine and its metabolites. The legally allowable level for S(+) Amphetamine is set at 1000 ng/mL in urine by the confirmatory GC/MS method as specified by the Substance Abuse and Mental Health Services Administration (SAMHSA) on Drug Abuse.

Note: This test provides only a preliminary analytical result which should be confirmed by a more specific method. Gas chromatography/ mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the National Institute on Drug Abuse (NIDA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

PRINCIPLE OF THE TEST

The One Step Test for Amphetamine is based on the principle of a competitive inhibition immunoassay, in which a chemically labeled drug (drug conjugate) competes with the drug which may be present in urine for the limited number of antibody binding sites. The test device consists of a membrane strip, which is pre-coated with Amphetamine-BSA conjugate on the test band region, and a colored anti-amphetamine monoclonal antibody-colloid gold conjugate pad placed at the end of the membrane.

In the absence of the drug in the urine, the colored antibody-colloid gold conjugate moves with the sample fluid by capillary action along the membrane until it reaches the immobilized drug conjugate in the test band region. At this point, the antibody-colloid gold conjugate reacts with the pre-coated drug conjugate to produce a visible red colored line as the antibodies form complexes with the drug conjugate. The formation of a visible color line on the test band region indicates the urine sample tested is negative for amphetamine.

When the drug is present in the urine, the drug/metabolite antigen will compete with the drug conjugate coated in the test band region for the limited antibody sites. When a sufficient concentration of drug is present, it will fill the limited antibody binding sites, and thus preventing the attachment of the colored antibody-colloid gold conjugate to drug conjugates pre-coated in the test band region. An absence of the color band on the test region indicates a positive result.

A control band with a different antigen/antibody reaction is also added to membrane strip to indicate that the test is performed properly. This control line should always be seen. A negative urine sample produces two distinct color bands. A positive sample produces only one color band in the control zone.

SPECIMEN COLLECTION

A fresh urine specimen should be used, no special pre-treatment is necessary. The specimen may be refrigerated (2-8oC) and stored up to 2 days, or frozen (-20oC or below) prior to assaying. If samples are refrigerated they should be brought to room temperature before testing.

TEST PROCEDURE

1. Bring the test pouch to room temperature. To begin testing, open the sealed pouch by tearing along the notch. Remove the test from the pouch.
2. Hold the test by the blue tape handle, and immerse the opposite end of the strip into the urine sample. Do not immerse past the white tape Mark line (see diagram). Take the strip out after 3-5 seconds and lay the strip flat on a clean, dry, non-absorbent surface (e.g. mouth of the urine container).
3. Wait for colored bands to appear. Read results after 10 minutes. Results obtained after more than 15 minutes are not considered valid.

INTERPRETATION OF RESULTS

Negative: In addition to one pink colored control (C) line in the control region, a distinct pink colored line will also appear in the patient test (T) region. The color intensity of the test line may be weaker or stronger than that of the control line.	Positive: Only one colored line appears in the control (C) region. No apparent line in the patient test (T) region. This indicates the presence of a drug/metabolite at a level of 300 ng/mL or above.

Note: A faint line on the test region indicates the methamphetamine in sample is near the cut-off level for the test. These samples should be re-tested or confirmed with a more specific method before a clinical determination is made

STORAGE AND STABILITY

The test kit can be stored at temperatures between 2 to 30°C in the sealed pouch to the date of expiration. The test kit should be kept away from direct sunlight, moisture and heat.

PRECAUTION

1. For in vitro diagnostic use only.
2. Do not use test kit beyond the expiry date.
3. The test device should not be reused.
4. Urine specimens may be infectious; insure proper handling and dispose of all used reaction devices into a biohazard container.